Our Practice
OTC Markets Compliance
An OTC company must provide timely, accurate, and sufficiently comprehensive information under the framework applicable to its reporting status and market tier.
The pathway may involve:
- SEC reports
- Regulation A reports
- Regulation Crowdfunding reports
- Bank regulatory reports
- OTC Markets alternative reporting
- Another qualifying disclosure framework
Capital Markets Law Group assists OTC issuers with disclosure, SEC reporting, corporate actions, quotation matters, securities offerings, and market-status compliance.
What Information Must an OTC Company Disclose?
Disclosure may address:
- Business and operating history
- Officers, directors, and control persons
- Capitalization
- Beneficial ownership
- Financial condition and results
- Material agreements
- Securities offerings and issuances
- Related-party transactions
- Legal proceedings
- Acquisitions and dispositions
- Corporate actions
- Transfer-agent information
- Shell-company status
- Material risks and developments
How Does SEC Reporting Affect OTC Status?
Late or missing reports may affect:
- OTC market designation
- Broker-dealer quotation activity
- Rule 144 availability for shareholders
- Financing transactions
- Transfer-agent matters
- Investor confidence
- Registration-form eligibility
Becoming current may require delinquent audits, quarterly reviews, periodic reports, and current reports.
What Is Rule 15c2-11?
Rule 15c2-11 governs when broker-dealers may initiate or publish quotations for OTC securities. It generally requires specified issuer information to be current and publicly available, subject to applicable exceptions.
Current disclosure does not guarantee quotations or a particular market designation.
When Should Counsel Become Involved?
Before the reporting calendar slips. Market tier, quotation activity, shareholder resales, and financing plans all depend on current status, and each missed report narrows the options. Early counsel review covers:
- Mapping the company's reporting pathway and its deadlines
- Planning catch-up filings before tier or quotation status is affected
- Reviewing disclosure for consistency with the capitalization record
- Addressing shell-company history and its disclosure consequences
- Coordinating corporate actions with the market's requirements
What Documents Are Involved?
Common documents include:
- SEC annual, quarterly, and current reports
- Regulation A or other qualifying reports, where applicable
- OTC Markets disclosure submissions and company updates
- Audited financial statements and reviews
- Capitalization and transfer-agent records
- Corporate-action documentation
- Attorney letters or counsel certifications where the pathway requires them
What Can Cause a Company to Lose Current Status?
Potential problems include:
- Late reports
- Missing financial statements
- Inadequate event disclosure
- Unresolved shell-company disclosure
- Inconsistent capitalization
- Undisclosed securities issuances
- Missing ownership or management information
- Inadequate control-change disclosure
- Transfer-agent issues
- Promotional or regulatory concerns
- Failure to respond to information requests
What Commonly Happens After a Status Problem?
Market tiers and quotation status are not static. A company that loses current status can expect effects across the market: designation changes, broker-dealer quotation decisions, transfer-agent caution, slower financings, and questions from shareholders whose resales depend on current information. Restoring status generally requires the missing disclosure, possibly with audits, and a review of the underlying record for consistency.
How Does Capital Markets Law Group Help?
Our services may include:
- Evaluating the reporting pathway
- Reviewing current and delinquent disclosure
- Preparing SEC or qualifying OTC disclosure
- Coordinating audits
- Reviewing capitalization and issuances
- Addressing shell history
- Preparing material-event disclosure
- Coordinating with transfer agents
- Supporting quotation matters
- Advising on continuing compliance
Keep Reading: Nasdaq and NYSE American Uplistings, Nasdaq Listing Applications and Uplisting Counsel, SEC Securities Offerings, Going Public and Form S-1 Registration Statements.
Frequently Asked Questions
Does OTC Markets Approve an Issuer's Disclosure?
OTC Markets may review information for compliance with its standards. The issuer remains responsible for accuracy and completeness.
Does Current Status Guarantee Active Trading?
No. Trading depends on broker-dealers, liquidity, investor interest, and market conditions.
Can a Delinquent SEC Filer Switch to Alternative Reporting?
A company generally cannot avoid existing SEC reporting obligations by publishing alternative disclosure.
How Quickly Can a Company Become Current?
Timing depends on the missing reports, audit status, records, corporate history, and management responsiveness.
Does Current OTC Status Make the Shares Freely Tradable?
No. Current information status is separate from each holder's resale analysis. Restricted shares still require Rule 144, a resale registration, or another exemption, and affiliates remain subject to volume and manner-of-sale limits.
What Is the Difference Between OTC Markets Tiers?
OTC Markets operates market tiers with different disclosure and eligibility standards, and the applicable tier depends on the issuer's reporting framework and qualification status. The specific tier requirements are published by OTC Markets, and the company should verify the current standards for its situation with its counsel and the market itself.
Can the Company Use OTC Disclosure Instead of SEC Reporting?
Only where the company's status permits it. A company that is subject to SEC reporting must satisfy those obligations, and alternative disclosure does not substitute for them.
Get Started
Talk to Capital Markets Law Group About OTC Compliance
Capital Markets Law Group assists OTC issuers with disclosure, delinquent reporting, corporate actions, financing, quotation eligibility, and continuing compliance. Contact the firm with the company's current reporting pathway and any deadlines approaching.